# Q3C Impurities: Residual Solvents_2011 - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/q3c-impurities-residual-solvents_2011/b949f32c-660b-4c85-9e90-3fc9286ced2a

> FDA guidance document: Q3C Impurities: Residual Solvents_2011. Issue date: December 24, 1997. Get complete insights and analysis.

---

## Details

- Title: Q3C Impurities: Residual Solvents_2011
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1997-12-24
- Last Changed: 2020-04-08
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1997-D-0381">FDA-1997-D-0381</a>

## Related Documents

- [E2BM Data Elements for Transmission Of Individual Case Safety Reports](https://www.globalkeysolutions.net/guidances/guidance-document/e2bm-data-elements-for-transmission-of-individual-case-safety-reports/ee70791b-0ecd-42b4-94aa-27632314cfa8)
- [Q1D Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products](https://www.globalkeysolutions.net/guidances/guidance-document/q1d-bracketing-and-matrixing-designs-for-stability-testing-of-new-drug-substances-and-products/b98c22b1-6e33-4f5b-a59c-3fcc41d1104c)
- [E9 Statistical Principles for Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/e9-statistical-principles-for-clinical-trials/d427b5ed-dd16-417e-adc2-9f35d3a3df23)